Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer

Predicting the risk of metastasis before starting prostate cancer (PCa) treatment can minimize the overtreatment of indolent cases and help choosing appropriate treatment. The levels of circulating microRNAs (miRNAs) from body fluids can be used as noninvasive prognostic biomarkers. In this study, u...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Sun, Park, Yong Hyun, Jung, Seung-Hyun, Jang, Sun-Hee, Kim, Mee Young, Lee, Ji Youl, Chung, Yeun–Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196022/
https://www.ncbi.nlm.nih.gov/pubmed/34117264
http://dx.doi.org/10.1038/s41525-021-00212-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196022/
https://www.ncbi.nlm.nih.gov/pubmed/34117264
http://dx.doi.org/10.1038/s41525-021-00212-w

Ejemplares similares